IMP

Giới thiệu công ty

Imexpharm Pharmaceutical Joint Stock Company (IMP), formerly Dong Thap pharmaceutical enterprises, was established in 1983. In 2001, The company transformed into a joint stock company. The primary business of IMP is manufacturing, exporting, and importing pharmaceutical products, materials, and medical facilities. The company owns two main factories located in the headquarters of Dong Thap province, according to GMP-ASEAN standards, and the warehouse system according to GLP-ASEAN standards. IMP was granted a European visa for the drug product Cephalexin 500mg and a WHO-GMP certificate for a he...